Both Retatrutide and Semaglutide are new medications designed for managing hyperglycemia and encouraging slimming. However, they work through slightly different processes . Wegovy is a GLP-1 receptor area agonist , while Novo Nord's Dual GIP/GLP-1 acts as a dual GIP and GLP-1 activator , potentially offering a greater impact on combined glycemic… Read More